Filing Details
- Accession Number:
- 0001209191-18-048513
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-27 17:03:22
- Reporting Period:
- 2018-08-23
- Accepted Time:
- 2018-08-27 17:03:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 924717 | Surmodics Inc | SRDX | Surgical & Medical Instruments & Apparatus (3841) | 411356149 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1304052 | S Gregg Sutton | 9924 West 74Th Street Eden Prairie MN 55344 | Vp Of Research And Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-23 | 10,544 | $19.42 | 19,853 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-08-23 | 4,280 | $23.95 | 24,133 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-23 | 14,204 | $74.11 | 9,929 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-08-23 | 620 | $74.94 | 9,309 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-08-23 | 10,544 | $0.00 | 10,544 | $19.42 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-08-23 | 4,280 | $0.00 | 4,280 | $23.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,544 | 2023-02-16 | No | 4 | M | Direct | |
| 12,841 | 2023-11-30 | No | 4 | M | Direct |
Footnotes
- Includes 497 shares acquired through the Employee Stock Purchase Plan for the phase ending in February 2018.
- Reflects the weighted average price of 14,204 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 23, 2018 with sale prices ranging from $73.80 to $74.75 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average price of 620 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 23, 2018 with sale prices ranging from $74.825 to $75.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The award vests in four equal installments on each of the first four anniversaries of the February 16, 2016 grant date.
- The award vests in four equal installments on each of the first four anniversaries of the November 30, 2016 grant date.
Billionaire Hedge Funds
